Tag - Frank Takkinen

Lake Street Capital Markets launched coverage of Profound Medical (NASDAQ:PROF; TSX:PRN) with a “buy” rating and $22 (U.S.) price target. The stock closed at $15.11 on Sept. 10. Profound develops, manufactures, and...